In vitro activity of a new carbapenem antibiotic, BO-2727, with potent antipseudomonal activity.
AUTOR(ES)
Nakagawa, S
RESUMO
BO-2727, a new 1-beta-methyl-carbapenem, was active at concentrations of 6.25 micrograms/ml or less against gram-positive and gram-negative bacteria, including some imipenem- and/or meropenem-resistant (MICs, > or = 12.5 micrograms/ml) Pseudomonas aeruginosa strains, against which it proved generally fourfold more active than imipenem and meropenem. BO-2727's antipseudomonal activity and its broad spectrum merit further investigation for clinical use by itself, since it was stable in the presence of renal dehydropeptidase I.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=192804Documentos Relacionados
- Mechanism of enhanced antipseudomonal activity of BO-2727, a new injectable 1-beta-methyl carbapenem.
- In vitro and in vivo antibacterial activities of BO-2727, a new carbapenem.
- In vitro activity of BMS-181139, a new carbapenem with potent antipseudomonal activity.
- In vitro antibacterial activity and beta-lactamase stability of a new carbapenem, BO-2727.
- In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity.
